id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2014-D-2175-0041,FDA,FDA-2014-D-2175,"Recommendations for Assessment of Blood Donor Eligibility, Donor Deferral and Blood Product Management in Response to Ebola Virus Guidance for Industry",Other,Guidance,2017-01-10T05:00:00Z,2017,1,2017-01-10T05:00:00Z,,2024-11-12T06:17:52Z,,1,0,090000648245701d
FDA-2014-D-2175-0040,FDA,FDA-2014-D-2175,"Recommendations for Assessment of Blood Donor Eligibility, Donor Deferral and Blood Product Management in Response to Ebola Virus; Guidance for Industry; Availability",Notice,Notice of Availability,2017-01-10T05:00:00Z,2017,1,2017-01-10T05:00:00Z,,2017-01-10T14:40:59Z,2017-00200,0,0,0900006482456a50